Carolyn Brady

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Matthew J. Ellis, Andrew Coop, Baljit Singh et al. · Journal of Clinical Oncology · 2001 · 1.1K citations · Full text

Medicine, Endocrinology, Oncology +17

Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer

A Lipton, Laurence M. Demers, Harold A. Harvey et al. · Cancer · 1995 · 113 citations

Medicine, Oncology, Pharmacology +17

The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer

Laurence M. Demers, Allan Lipton, Harold A. Harvey et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1993 · 82 citations

Medicine, Endocrinology, Oncology +15

Effect of Rioprostil on Aspirin‐induced Gastrointestinal Mucosal Changes in Normal Volunteers

Keith G. Tolman, Mark K. Detweiler, Craig A. Harrison et al. · The Journal of Clinical Pharmacology · 1988 · 11 citations

Medicine, Pharmacology, Pharmacotherapy +13